Clinical Trial Update: Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Pegylated Somatropin in children with Growth Hormone Deficiency; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Pegylated Somatropin (pegylated human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Growth Hormone Deficiency | Phase 4 | Status: UNKNOWN